Sensodyne's brand purpose is to create an oral care future that is sensitivity‐free; we wanted to create a mobile-first digital experience that would help the brand achieve this goal. While the legacy ...

Haleon was formed in 2019 by the merger of the consumer healthcare businesses of British pharmaceutical group GSK and US ...

Pfizer will sell its remaining stake in British consumer healthcare group Haleon , the companies said on Tuesday.

Haleon is to axe diversity targets from its executive bonus scheme in the latest sign that UK businesses are rowing back on ...

Pfizer Inc. is looking to sell its remaining 7.3% stake in Haleon Plc, culminating a multi-year separation from the maker of ...

With Pfizer’s final stake sale in the bag, the two Big Pharma companies behind Haleon’s genesis have formally parted ways with the standalone consumer health giant. | After charting similar moves ...

Ocado has watered down targets to get more ethnic minority people into senior roles amid a wider rollback of diversity ...

Bengaluru] Drugmaker Pfizer has sold its entire stake in Haleon for about US$3.24 billion to institutional investors and the ...

Pfizer (PFE) stock in focus as the company sells its entire 7.3% stake in Haleon (HLN) for $3.24B. Read more here.

The rebrand comes after GSK transferred its consumer health business to Haleon to focus on innovative drugs. Haleon will now encompass consumer health brands including Sensodyne, Panadol, Eno, and ...